← All Aquestive Therapeutics, INC filings

Aquestive Therapeutics, INC Form 4 insider transactions

NASDAQ
AQST
Aquestive Therapeutics, INC
Form 4: Aquestive Therapeutics SVP, Operations, Cassie Jung Reports Stock Transactions
Cassie Jung, SVP of Operations at Aquestive Therapeutics, reports acquisition and disposal of company stock and derivative securities.
NASDAQ
AQST
Aquestive Therapeutics, INC
Form 4: Aquestive Therapeutics Executive Peter E. Boyd Reports Stock and Option Awards
Peter E. Boyd, an executive at Aquestive Therapeutics, reported the acquisition of restricted stock and stock options, along with a correction to a previous filing regarding shares beneficially owned.
NASDAQ
AQST
Aquestive Therapeutics, INC
Form 4: Aquestive Therapeutics Executive Stephen Wargacki Reports Changes in Beneficial Ownership
Stephen Wargacki, SVP of Research & Development at Aquestive Therapeutics, reports acquisition and disposal of common stock and derivative securities.